Aldeyra Therapeutics, Inc. SEC filings ALDX
Aldeyra Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Oct 6, 2005. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 10, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 4, 2024 |
| DEF 14A | Proxy statement | May 23, 2023 | Jun 30, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Jun 7, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | Jun 8, 2021 |
| DEFA14A | Additional proxy material | Apr 27, 2020 | — |
| DEF 14A | Proxy statement | Apr 27, 2020 | Jun 9, 2020 |
| DEFA14A | Additional proxy material | Apr 22, 2019 | — |
| DEF 14A | Proxy statement | Apr 22, 2019 | Jun 4, 2019 |
| DEFA14A | Additional proxy material | Apr 25, 2018 | — |
| DEF 14A | Proxy statement | Apr 25, 2018 | Jun 7, 2018 |
| DEFA14A | Additional proxy material | Apr 24, 2017 | — |
| DEF 14A | Proxy statement | Apr 24, 2017 | Jun 8, 2017 |
| DEFA14A | Additional proxy material | Apr 25, 2016 | — |
| DEF 14A | Proxy statement | Apr 25, 2016 | Jun 9, 2016 |
| DEFA14A | Additional proxy material | Apr 27, 2015 | — |
| DEF 14A | Proxy statement | Apr 27, 2015 | Jun 9, 2015 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Concord, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1341235
- Former names
- Aldexa Therapeutics, Inc. (until Mar 4, 2014); Neuron Systems Inc (until Aug 1, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.